Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ERIC W RAASCH

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1700971173
CMS profile
1009954
Location
RALEIGH, NC

General Payments · PY2018–2024

$4,392.31

  • Reported across 233 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$778.58

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $778.58 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $389.02 25
PY2019 $821.71 54
PY2020 $299.66 18
PY2021 $370.42 20
PY2022 $891.63 42
PY2023 $841.29 38
PY2024 $778.58 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $14.26 11/19/2024 Food and Beverage Undisputed 01/23/2026 1145830821 CMS
Amgen Inc. $24.06 05/07/2024 Food and Beverage Undisputed 01/23/2026 1111681422 CMS
Amgen Inc. $31.11 05/24/2024 Food and Beverage Undisputed 01/23/2026 1111681424 CMS
Amgen Inc. $30.27 06/04/2024 Food and Beverage Undisputed 01/23/2026 1111681426 CMS
Amgen Inc. $16.74 12/11/2024 Food and Beverage Undisputed 01/23/2026 1117359292 CMS
AstraZeneca Pharmaceuticals LP $22.30 06/13/2024 Food and Beverage Undisputed 01/23/2026 1105747311 CMS
AstraZeneca Pharmaceuticals LP $17.75 08/06/2024 Food and Beverage Undisputed 01/23/2026 1105291866 CMS
AstraZeneca Pharmaceuticals LP $16.96 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104777690 CMS
Aurinia Pharma U.S., Inc. $15.21 01/19/2024 Food and Beverage Undisputed 01/23/2026 1150690033 CMS
Aurinia Pharma U.S., Inc. $16.46 03/14/2024 Food and Beverage Undisputed 01/23/2026 1150690035 CMS
Aurinia Pharma U.S., Inc. $20.78 04/25/2024 Food and Beverage Undisputed 01/23/2026 1150690037 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.22 01/25/2024 Food and Beverage Undisputed 01/23/2026 1086157314 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.25 03/06/2024 Food and Beverage Undisputed 01/23/2026 1086133514 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.45 06/13/2024 Food and Beverage Undisputed 01/23/2026 1086155666 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.96 06/18/2024 Food and Beverage Undisputed 01/23/2026 1086232388 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.09 12/21/2024 Food and Beverage Undisputed 01/23/2026 1086226802 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.60 07/30/2024 Food and Beverage Undisputed 01/23/2026 1118121415 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.38 08/21/2024 Food and Beverage Undisputed 01/23/2026 1118121411 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.54 09/13/2024 Food and Beverage Undisputed 01/23/2026 1118121413 CMS
Fresenius USA Marketing, Inc. $24.30 03/20/2024 Food and Beverage Undisputed 01/23/2026 1154209130 CMS
Fresenius USA Marketing, Inc. $22.07 04/19/2024 Food and Beverage Undisputed 01/23/2026 1154209128 CMS
GlaxoSmithKline, LLC. $18.82 09/11/2024 Food and Beverage Undisputed 01/23/2026 1116635794 CMS
GlaxoSmithKline, LLC. $20.36 10/22/2024 Food and Beverage Undisputed 01/23/2026 1116651075 CMS
Lilly USA, LLC $24.72 03/26/2024 Food and Beverage Undisputed 01/23/2026 1134967983 CMS
Mallinckrodt Hospital Products Inc. $39.55 02/15/2024 Food and Beverage Undisputed 01/23/2026 1145122999 CMS
Mallinckrodt Hospital Products Inc. $25.99 05/30/2024 Food and Beverage Undisputed 01/23/2026 1145123003 CMS
Mallinckrodt Hospital Products Inc. $18.79 08/12/2024 Food and Beverage Undisputed 01/23/2026 1145123007 CMS
Mallinckrodt Hospital Products Inc. $14.92 10/22/2024 Food and Beverage Undisputed 01/23/2026 1145123011 CMS
Novo Nordisk Inc $23.51 08/27/2024 Food and Beverage Undisputed 01/23/2026 1097486700 CMS
Novo Nordisk Inc $13.81 09/24/2024 Food and Beverage Undisputed 01/23/2026 1096873739 CMS
Otsuka America Pharmaceutical, Inc. $26.42 01/19/2024 Food and Beverage Undisputed 01/23/2026 1118965231 CMS
Otsuka America Pharmaceutical, Inc. $28.66 05/02/2024 Food and Beverage Undisputed 01/23/2026 1118965233 CMS
Otsuka America Pharmaceutical, Inc. $25.78 05/21/2024 Food and Beverage Undisputed 01/23/2026 1118965235 CMS
Otsuka America Pharmaceutical, Inc. $22.51 07/02/2024 Food and Beverage Undisputed 01/23/2026 1118965237 CMS
Otsuka America Pharmaceutical, Inc. $17.43 08/29/2024 Food and Beverage Undisputed 01/23/2026 1118965239 CMS
Travere Therapeutics, Inc. $23.55 10/29/2024 Food and Beverage Undisputed 01/23/2026 1149874666 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.